This invention was made with government support under Grant Numbers CA50239. The government has certain rights in this invention.
Entry |
---|
Oltavi and Korsmeyer, Checkpoints of Dueling Dimers Foil Death Wishes, Cell 79:189-192, 1994. |
Bakhshi et al., Cloning the Chromosomal Breakpoint of t(14;18) Human Lymphomas: Clustering around J.sub.H on Chromosome 14 and near a Transcriptional Unit on 18, Cell 41:899-906, 1985. |
Tsujimoto et al., The t(14;18) Chromosome Translocations Involved in B-Cell Neoplasms Result from Mistakes in VDJ Joining, Science 229:1390-1393, 1985. |
Cleary and Sklar, Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18, Proc. Natl. Acad. Sci. USA 82:7439-7443, 1985. |
Korsmeyer, Bcl-2 Initiates a New Category of Oncogenes: Regulators of Cell Death, Blood 80:879-886, 1992. |
Yin et al., BH1 and BH2 domains of Bcl-2 are Required for Inhibition of Apoptosis and Heterodimerization with Bax, Nature 369:321-323, 1994. |
Boyd et al., Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins, Oncogene 11:1921-1928, 1995. |
Chittenden et al., A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions, Embo. J. 14:5589-5596, 1995. |
Farrow and Brown, New Members of the Bcl-2 Family and their Protein Partners, Curr. Opin. Genet. Dev. 6:45-49, 1996. |
Oltvai et al., Bcl-2 Heterodimerizes In Vivo with a Conserved Homolog, Bax, that Accelerates Programmed Cell Death, Cell 74:609-619, 1993. |
Yang et al., Bad, A Heteroclimeric Partner For Bcl-xL & Bcl-2, Displaces Bax & Promotes Cell death, Cell 80:285-291, 1995. |
Muslin et al., Interaction of 14-3-3 with Signaling Proteins is Mediated by the Recognition of Phosphoserine, Cell 84:889-897, 1996. |
Furukawa et al., Biochem. Biophys. Res. Comm. 194:144-149, 1993. |
Cross et al, Purification of CpG islands using a methylated DNA binding column, Nature Genet. 6:236-244, 1994. |
Cohen, The Structure and Regulation of Protein Phosphatases, Ann. Rev. Biochem. 58:453-508, 1989. |
Wera and Hemmings, Serine/threonine protein phosphatases, Biochem. J. 311:17-29, 1995. |
Shenolikar, Protein phosphatase regulation by endogenous inhibitors, Cancer Biol. 6:219-227,1995. |
Matthews, Protein Kinases and Phosphatases that act on Histidine, Lysine, or Arginine Residues in Eukaryotic Proteins: A Possible Regulator of the Mitogen-activated Protein Kinase Cascade, Pharmac. Ther. 67:323-350, 1995. |
Levitski, Signal-transduction therapy, Eur. J. Biochem. 226:1-13, 1994. |
BLAST Search Accession No. Z57098, Oct. 18, 1995. |
BLAST Search Accession No. Z57099, Oct. 18, 1995. |
Sambrook et al Molecular Cloning: A Laboratory Manual Second Edition vol. 2 Chapter 15, 1989. |
Lazar et al Molecular adn Cellular Biology vol. 8 No. 3 1247-1252, Mar. 1988. |
Burgess et al Journal of Cell biology vol. 111 2129-2138., Nov. 1990. |
Schwartz et al Proc Natl Acad Sci USA vol. 84 6408-6411, Sep. 1987. |
Lin et al Biochemistry vol. 14 No. 8 1559-1563, 1975. |